ArticleFrontiers in medicine2026
Persistent intrahepatic cholestasis secondary to multiple etiologies: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intrahepatic cholestasis may arise from multiple etiologies, but it is particularly challenging to identify its primary etiology, especially when several potential contributors overlap and the disease itself progresses over time. Herein, we report a 42-year-old man with adult-onset Still's disease (AOSD) who developed persistent severe intrahepatic cholestasis. At early stage of this disease, intrahepatic cholestasis was attributed to severe liver injury secondary to AOSD and drug-induced liver injury. Subsequently, sepsis developed, which might be associated with the use of glucocorticoids and contamination of central venous catheter, and aggravated intrahepatic cholestasis. Finally, the patient's condition was gradually improved after catheter removal and targeted antibiotic therapy. This case highlights the importance of etiological reassessment in the management of persistent intrahepatic cholestasis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.